verified SJR 0,288 · Q3 • database Scopus / SJR & Web of Science indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q3 — Infectious Diseases lock Subscription

Current HIV Research

Current HIV Research is a journal indexed in SJR in Infectious Diseases and Virology with an H index of 60. It has a price of 2040 €. It has an SJR impact factor of 0,288 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,288.

ISSN: 1570-162X

Publisher: Bentham Science Publishers

Category: Infectious Diseases

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,288 Q3

H-index 60

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.040 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,288

H-index

Docs (year)

Docs 3y

147

Total refs

1710

Cites 3y

131

Citable 3y

141

Cites/Doc 2y

0.97

Ref/Doc

34.9

Immediate OA

2040 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cocaine and HIV-1 Interplay in CNS: Cellular and Molecular Mechanisms

Using A Sociological Model to Analyze Access to Pediatric HIV/AIDS Care in Rural Sub-Saharan Africas

Exploiting Structurally Diverse Nucleoside Analogs as Probes of Reverse Transcription Complexes

Evaluating the Role of Etravirine in the Second-Line Antiretroviral Therapy After Failing an Initial Non-Nucleoside Reverse Transcriptase Inhibitor- Based Regimen in a Resource-Limited Setting§

Etravirine in the Treatment of HIV-1: A Clinical Overview for Healthcare Professionals

Effective Evidence-Based Programs For Preventing Sexually-Transmitted Infections: A Meta-Analysis

Editorial [Hot topic: The Significance of HIV-1 Genetic Diversity for Vaccine Development (Guest Editor: Michael M. Thomson)]

Editorial

Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

Differential Effects of Efavirenz and Lopinavir/Ritonavir on Human Adipocyte Differentiation, Gene Expression and Release of Adipokines and Pro-Inflammatory Cytokines.

Correlations Between HIV-1 Clades and HIV-1 Antibody Neutralization Sensitivity: Significant for Vaccine Development?

Correlates of Unprotected Anal Intercourse in HIV Positive Men Attending an HIV/AIDS Clinic in Sydney§

SHOW MORE ARTICLES

Comparison of Protease Inhibitor (PI) Resistance-Associated Mutations Between PI-Naive and PI-Experienced HIV-1 Infected Patients in Thailand Where Subtype A/E is Predominant

Abnormal Cytokine Production by Circulating Monocytes and Dendritic Cells of Myeloid Origin in ART-Treated HIV-1+ Patients Relates to CD4+ T-Cell Recovery and HCV Co-Infection

Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients

Chronic Diarrhea and AIDS: Insights into Studies with Non-Human Primates

Chemokine Receptors Expression on T Cells and Response to HAART Among Chronic HIV-1-Infected Subjects

Broadly Neutralizing Antibodies and their Significance for HIV-1 Vaccines

Barriers and Facilitators for Adherence to Antiretroviral Therapy in Papua New Guinea

Articulating A Rights-Based Approach to HIV Treatment and Prevention Interventions

Antiretroviral Therapeutic Drug Monitoring in HIV-Infected Pregnant Women: Maternal Immunovirological Outcome at Delivery and During the 18 Month Follow-Up Period

Anti-HIV-1 Gene Expressing Lentiviral Vectors as an Adjunctive Therapy for HIV-1 Infection

Analysis of Vpr Genetic Variations between Chinese Major Circulating Recombinants CRF01_AE and CRF07_BC

An Effective HIV Vaccine: A Combination of Humoral and Cellular Immunity?

FAQs

Current HIV Research has an SJR of 0,288 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2040 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current HIV Research is 30%.

Current HIV Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current HIV Research?

What is the APC / publication cost?

What is the acceptance rate?